Certificates of Confidentiality:

Slides:



Advertisements
Similar presentations
1 The HIPAA Privacy Rule and Research This presentation will probably involve audience discussion, which will create action items. Use PowerPoint to keep.
Advertisements

HIPAA – Privacy Rule and Research USCRF Research Educational Series March 19, 2003.
Exempt Research Mary Banks BS, BSN IRB Director CRC IRB and BUMC IRB.
 Federal regulations specify “engagement” at the institutional level  Cornell has a Federalwide Assurance specifying its commitment to comply with regulations.
CUMC IRB Investigator Meeting November 9, 2004 Research Use of Stored Data and Tissues.
8 Criteria for IRB Approval of Research 45 CFR (a)
Informed Consent and HIPAA Tim Noe Coordinating Center.
IRB Monthly Investigator Meeting Columbia University Medical Center IRB October 11, 2005.
Have You Read Your Medical Record? Peggy Beck, RHIA, CMT, FAAMT.
Human Investigation Committee  Is it research?  If yes, does it involve human subjects?  If yes, can it be exempt?  If no, will a Request for.
Privacy vs. Confidentiality Presentation for IRB Members.
Is this Research? Exempt? Expedited?
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
International Research & Research Involving Children K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development.
International Human Subject Research Legal and Ethical Considerations for Investigators Theresa J. Colecchia, Esq. Associate General Counsel May 8, 2006.
Help us Help you: IRB Policy Updates Susan Bankowski, MS, JD IRB Chair.
Future Use of Stored Samples & Data and the NIH Policy on GWAS and dbGaP NIAID/DAIDS Dione Washington, M.S. -- ProPEP Sudha Srinivasan, Ph.D.-- TRP Tanisha.
Confidentiality Issues in Research with Human Subjects Sarah Frankel, Ph.D. Human Studies Committee Washington University.
HIPAA and Research Basics for IRB Tim Atkinson Director, Research and Sponsored Programs Director, Institutional Review Board Research Privacy Officer.
Risk by Richard R. Riker MD Vice-Chair, IRB Maine Medical Center.
Confidentiality, Research, & Law
1 Ethics of Working with Human Subjects (BIOL/CHEM 397 ) Header image designed by Michelle Jordan, UMBC Creative Services, 2009.
H I P A A T R A I N I N G Self Directed Module 7 Research Disclosures For Data Custodians START Click to begin…
HIPAA SURVIVAL SKILLS: An Update University of Miami1 Marisabel Davalos, M.S.Ed., CIP Associate Director of Educational Initiatives November, 2008.
Privacy and Confidentiality. Definitions n Privacy - having control over the extent, timing, and circumstances of sharing oneself (physically, behaviorally,
The Linguistics Department Institutional Review Board Committee Silvina Montrul, chair Fred Davidson Irene Koshik Ryan Shosted September 22, 2008.
A step-by-step guide to help you determine if your research protocol is required to be reviewed by the Lindenwood University IRB INSTITUTIONAL REVIEW BOARD.
Privacy vs. Confidentiality.  IRB review of privacy and confidentiality protections is required under the Common Rule and the FDA regulations, as well.
Institutional Review Board Procedures and Implications After the applied dissertation committee has approved the proposal and the IRB package, the student.
Human Subjects Issues Surrounding Ethanol Administration in Humans ARTSS Summer Program June 6, 2011.
Institutional Review Board Issues for Classroom Research Sharon McWhorter IRB Administrator, The University of Akron (With assistance from Phil Allen,
Health Insurance portability and Accountability Act (HIPAA)‏
A Road Map to Research at Jefferson: HIPAA Privacy and Security Rules for Researchers Presented By: Privacy Officer/Office of Legal Counsel October 2015.
Research Orientation to SCCA. What is the SCCA? The SCCA brings together the outstanding adult and pediatric oncology patient care services of three world-
HIPAA and Human Subjects Research IRB Member CE May 2014 Slideshow by Sean Horkheimer.
Investigational Devices and Humanitarian Use Devices June 2007.
Case Studies: Puzzles in Human Research Kevin L. Nellis, M.S., M.T. (A.S.C.P.) Program Analyst, Program for Research Integrity Development and Education.
HRPP Policies & Forms Chapter Two Created/Revised for AAHRPP June 1, 2007.
Human Research Protection Program 101 March 20, 2007 Cincinnati, OH.
Human Subjects Update E. Wethington, Chair, UCHS.
HUMAN SUBJECTS QUIZ! TRUE OR FALSE?
Created by Steve Martin, PA-C IRB Application Received Exempt Complete Yes No Mississippi College IRB Application Process Determine Review Category Expedited.
Bussara Sukpanichnant, Human Subject Protection Office, USAMD-AFRIMS Unanticipated Problems 15 th FERCAP International Conference 24 Nov 15 Nagasaki, Japan.
HIPAA and Transitions Protected Health Information PHI.
Nothing Certificates of Confidentiality: Uses and Limitations as Protection for genetic research on addiction Zita Lazzarini, JD, MPH Division of Public.
Introduction Review and proper registration of Human Gene Transfer protocols is very complex. A protocol goes through rigorous review by multiple Committees.
Conditional IRB Approval
Susan Sonne, PharmD, BCPP Chair, MUSC IRB II
Dartmouth CPHS February 7, 2017
What is a Certificate of Confidentiality?
Certificates of Confidentiality
HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT (HIPAA)
Clinicaltrials.gov Update
The HIPAA Privacy Rule: Implications for Medical Research
Protection of Human Subjects In Research
The 2018 Human Subject Rules
Human Research Protection Program (HRPP) Brown Bag Series October 2017
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
The HIPAA Privacy Rule and Research
New NIH Human Subjects & Clinical Trials Information
This takes approximately 5 minutes or less from start to finish
UW-Madison Central IRB Gateway
Basic Practice of Statistics - 3rd Edition Lecture PowerPoint Slides
The 2018 Human Subject Rules
Elements of a Successful Informed Consent
What types of research are exempt and ohrp guidance on exemptions
FERPA For New Faculty Lawrence F. Glick Sr. Associate General Counsel
What are the Major Changes to the IRB under the Final Common Rule?
IRB Educational Session - IRB Regulations on Expedited Review
Understanding the Process of Documenting Informed Consent
Presentation transcript:

Certificates of Confidentiality: When Are They Needed and Whom Do They Protect? Susan Sonne, PharmD, BCPP Associate Professor of Psychiatry Associate Director of SCTR RKS Program Chair, IRB II

What is a CoC? Provides a layer of privacy protection for participants enrolled in studies collecting sensitive information. Protects the INVESTIGATOR from being forced to disclose information that identifies a person as a study participant – even under subpoena or court order. Typically issued by NIH or FDA—can be issued even for unfunded studies

What is a CoC (continued) CoCs expire and must be renewed to protect new data CoCs are permanent—any information protected under the CoC is protected permanently CoCs can be retroactive—once a CoC is in place, it can protect all info previously collected (as long as there has not been a subpoena or court order prior to the issuance of the CoC)

What is the purpose of a CoC? To enable participants to provide truthful information without risk of criminal or civil action May improve recruitment for studies collecting sensitive information

What is considered sensitive? Research on HIV, Acquired Immune Deficiency Syndrome (AIDS), and other sexually transmitted diseases (STD) Studies that collect information on sexual attitudes, preferences, or practices Studies on the use of alcohol, drugs, or other addictive products Studies that collect information on illegal conduct Studies that gather information that if released could be damaging to a participant's financial standing, employability, or reputation within the community Research involving information that might lead to social stigmatization or discrimination if it were disclosed Research on participants' psychological well-being or mental health Genetic studies, including those that collect and store biological samples for future use

What does a CoC protect? A CoC only protects an investigator from disclosing a participants’ identity as a research participant – not the research data. If the identity is known, any research data would be discoverable.

Important Points Information in the medical record is always subject to subpoena or court order It cannot be guaranteed that information that identifies a person as a study participant in the medical record could be protected by a CoC (at least at MUSC).

What studies should not have a CoC? Studies not collecting sensitive data Studies collecting sensitive data solely from the medical record (MUSC policy) Studies that require study participation to be documented in the medical record for the purposes of clinical billing to insurance (MUSC policy)

What is the institutional commitment? The Institution is responsible for upholding the CoC and providing appropriate legal counsel if warranted

CoC Requirements CoC is only considered valid if the PI has signed an assurance that the PI will uphold the CoC If PI changes, there must be an assurance signed by the new PI for the CoC to still be valid There should be sign off by the an Institutional Official (a designated individual within the Office of Research and Sponsored Programs). There should be language in the IRB-approved informed consent document that describes the additional protections afforded by the CoC

Investigator-Initiated CoCs (at MUSC) PI must obtain institutional approval for CoC by submitting a completed CoC checklist to ORSP An authorized official within ORSP will determine the appropriateness of a CoC The PI will maintain a copy of the CoC application as well as the CoC for review/audit The PI will sign an assurance notice that s/he plans to uphold the CoC If the PI changes, the new PI will also sign an assurance

This form is how MUSC determines if a CoC is appropriate This form is how MUSC determines if a CoC is appropriate. Check with your institution to see how this would be done at your site.

Sponsor-Initiated CoCs It should be determined whether the sponsor is expecting your site to adhere to the CoC If MUSC is to adhere to the CoC, the PI submit a signed assurance letter, copy of the CoC and completed CoC checklist to ORSP If the CoC is only for a portion of the study (e.g. the biorepository) and MUSC would not be under it, appropriate language should be in the consent that the holder of the CoC is the sponsor but info in the MUSC medical record could still be subject to subpoena

Scenario 1 An investigator is collecting information on HIV status from the medical record and interviewing participants about sexual risk behaviors. No information regarding study participation would be in the medical record Is a CoC appropriate?

Scenario 2 An investigator is conducting a chart review and obtaining information on outcomes of patients who have had hip and knee surgeries. Is this information sensitive? Is a CoC appropriate?

Scenario 3 An investigator is participating in multi-site behavioral intervention for the treatment of cocaine dependence. The sponsor has obtained a CoC and wishes each clinical site to adhere to the CoC No information that would identify the participant would be in the medical record Is a CoC appropriate?

Scenario 4 An investigator is conducting an interview study regarding barriers to treatment with patients who have diabetes Is this information sensitive? Is a CoC appropriate?

Scenario 5 An investigator at your site is participating in multi-site medication trial for the treatment of skin cancer Information that would identify the participant will be in the medical record since the study intervention is part of clinical care and will be billed to insurance Does it make sense to have a CoC?

Scenario 5+ What if in the previous example: Tissue samples of affected skin will be sent to a biorepository for future genetic analysis. The sponsor has a CoC for the biorepository Would your site fall under the CoC? Why type of language would be in your site’s consent?

Summary Investigators should only consider getting a CoC if they are collecting sensitive information A CoC only protects a participant’s identity as a research participant. If the identity is known, any research data would be discoverable. Medical records may be subject to subpoena or court order If a study is only collecting information from the medical record, that information would already be discoverable and a CoC would not add additional protection

Where can I find more information? NIH Certificates of Confidentiality (CoC) Kiosk http://grants.nih.gov/grants/policy/coc/index.htm NIH Certificates of Confidentiality (CoC) FAQs http://grants.nih.gov/grants/policy/coc/faqs.htm#366 MUSC policy: http://academicdepartments.musc.edu/research/policies/ Research Toolkit http://academicdepartments.musc.edu/sctr/tools_links/tool kit_design.html